Business Context and Reporting Period
This Form 6-K filing by Immunocore Holdings Plc, dated April 14, 2022, serves as a notice of the Company's Annual General Meeting (AGM) scheduled for May 12, 2022. The filing distributes the notice of the AGM, proxy forms, and the UK Annual Report and accounts for the fiscal year ended December 31, 2021, to ordinary shareholders and American Depositary Share (ADS) holders.
Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. While the document references the distribution of the UK Annual Report containing accounts for the year ended December 31, 2021, the numerical data from that report is not included in this Form 6-K text.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The document is procedural, focusing on the logistics of the upcoming AGM and the distribution of voting materials to shareholders of record as of April 7, 2022.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk disclosures beyond the standard legal disclaimer that the information furnished is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 unless expressly incorporated by reference. The primary action item is the upcoming AGM where shareholders will vote on matters outlined in the distributed materials.
Key Facts for Investor Verification
- Verify the specific agenda items and resolutions to be voted on at the AGM by reviewing the Notice of Annual General Meeting (Exhibit 99.1).
- Confirm the voting record date of April 7, 2022, to determine eligibility to vote.
- Access the full UK Annual Report and accounts for the year ended December 31, 2021, via the Company's investor relations website to obtain detailed financial performance data not present in this filing.
- Note that the AGM will be held both physically at Cooley (UK) LLP in London and electronically via meetnow.global/IHCAGM2022.